Australia Prohibits Use of Genetic Test Results in Life Insurance Underwriting

Historically, life insurers could request and utilise genetic test results to assess risk and determine policy terms. This practice raised concerns about privacy and the potential for genetic discrimination, deterring many from seeking genetic testing that could inform proactive health measures. The new law addresses these issues by ensuring that genetic information cannot be used to influence life insurance applications, premiums, or coverage.

Dr. Jane Tiller, a prominent advocate for genetic privacy, highlighted the significance of this reform, noting that it aligns Australia with international standards and promotes public health initiatives. She emphasised that individuals can now pursue genetic testing for medical purposes without the added concern of how it might affect their insurance options.

For policyholders, this change means that existing and future life insurance policies will not be impacted by genetic test results. Insurers are required to adjust their underwriting processes accordingly, focusing on other health and lifestyle factors when assessing applications. This shift is expected to foster greater trust between consumers and insurers, as it removes a significant barrier to obtaining life insurance coverage.

Industry experts anticipate that the ban will lead to increased participation in genetic testing, enabling earlier detection and management of hereditary conditions. This proactive approach could ultimately reduce the incidence of severe health issues, benefiting both individuals and the broader healthcare system.

As the October 2026 implementation date approaches, life insurers are advised to review and update their underwriting guidelines to comply with the new legislation. Consumers are encouraged to stay informed about their rights and the protections afforded by this law, ensuring they can make informed decisions about their health and insurance needs.